Ligand raises FY24 EPS view to $5.00-$5.50 from $4.25-$4.75,consensus $4.64

The APEIRON acquisition will be immediately accretive to Ligand’s earnings per share by approximately $1.00 on an annualized basis. Ligand is increasing its 2024 revenue guidance to be in the range of $140M to $157M previously $130M to $142M and is raising core adjusted EPS guidance to $5.00 to $5.50 previously $4.25 to $4.75 Royalties are now expected to range from $100 million to $105 million Guidance for sales of Captiso is unchanged at $25 M to $2M and contract revenue is now expected to range from $15 M to $25 M previously $15M to $20M. Consensus for FY24 revenue is $137.79M.